Neurodegeneration in the course of AD is suspected to stem from alterations in amyloid precursor protein (APP) processing, resulting in the elevation of a pathogenic Aβ42 peptide in the brain and cerebrospinal fluid (CSF) [37]. Here, APP is linked to Alzheimer disease.